Nuvation Bio (NUVB) earnings, Aug 6, 2026: EPS −6%, stock −4.1%
In brief
Nuvation Bio reported on Aug 6, 2026. Earnings per share changed −6% year over year, 27.1% below the estimate; revenue +556%. The stock opened with a −4.9% gap and closed the day −4.1% (Aug 6, 2026). The stock is now 57.0% below its 52-week high, −14.8% over 12 months. Next report: Mar 11, 2027.
EPS vs estimate−27.1%
EPS, YoY−6%
Revenue, YoY+556%
Gap · day−4.9% · −4.1%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 6, 2026 | −4.9% | −4.1% |
Next-quarter estimates, ratings and the NUVB chart are in the terminal.
Open the terminalFAQ
When is Nuvation Bio's next earnings report?
Mar 11, 2027. The date comes from daily data and is corrected if the company moves it.
How did Nuvation Bio stock react to the report?
Opening gap −4.9%, day's result −4.1%.
Did Nuvation Bio's earnings grow?
Earnings per share fell 6% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.